Arvinas (ARVN) Stock Forecast & Price Target

$8.13 -0.48 (-5.57%)

Closing price 04:00 PM Eastern

Extended Trading

$8.39 +0.26 (+3.25%)

As of 07:57 PM Eastern

Arvinas - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 15 Analyst Ratings

Sell
0

Hold
5

Buy
10

Based on 15 Wall Street analysts who have issued ratings for Arvinas in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 15 analysts, 5 have given a hold rating, and 10 have given a buy rating for ARVN.

Consensus Price Target

$35.50
336.65% Upside

According to the 15 analysts' twelve-month price targets for Arvinas, the average price target is $35.50. The highest price target for ARVN is $81.00, while the lowest price target for ARVN is $12.00. The average price target represents a forecasted upside of 336.65% from the current price of $8.13.

Get the Latest News and Ratings for ARVN and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Arvinas and its competitors.

ARVN Analyst Ratings Over Time

Type	Current Forecast 3/25/24 to 3/25/25	1 Month Ago 2/24/24 to 2/23/25	3 Months Ago 12/26/23 to 12/25/24	1 Year Ago 3/26/23 to 3/25/24
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	10 Buy rating(s)	12 Buy rating(s)	14 Buy rating(s)	14 Buy rating(s)
Hold	5 Hold rating(s)	0 Hold rating(s)	1 Hold rating(s)	2 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$35.50	$60.00	$63.50	$59.93
Forecasted Upside	336.65% Upside	237.65% Upside	239.03% Upside	47.36% Upside
Consensus Rating	Moderate Buy	Buy	Moderate Buy	Moderate Buy

Remove Ads

ARVN Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

ARVN Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Arvinas Stock vs. The Competition

Type	Arvinas	Medical Companies	S&P 500
Consensus Rating Score	2.67	2.82	2.54
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	336.65% Upside	29,987.76% Upside	17.45% Upside
News Sentiment Rating	Positive News See Recent ARVN News	Positive News	Positive News

Remove Ads

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
3/13/2025	Morgan Stanley 3 of 5 stars	Terence Flynn Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Equal Weight ➝ Equal Weight	$48.00 ➝ $12.00	+39.94%
3/13/2025	Guggenheim 2 of 5 stars	Michael Schmidt Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy ➝ Buy	$57.00 ➝ $32.00	+275.45%
3/13/2025	The Goldman Sachs Group 3 of 5 stars	P. Choi Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Neutral	$70.00 ➝ $15.00	+66.11%
3/12/2025	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Etzer Darout Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Target	Outperform ➝ Outperform	$82.00 ➝ $20.00	+134.93%
3/12/2025	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Derek Archila Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Target	Overweight ➝ Overweight	$60.00 ➝ $26.00	+205.42%
3/12/2025	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Tazeen Ahmad Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy ➝ Buy	$54.00 ➝ $28.00	+237.35%
3/12/2025	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Robert Driscoll Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Neutral	$57.00 ➝ $12.00	+44.58%
3/11/2025	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrew Fein Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$81.00 ➝ $81.00	+853.61%
3/11/2025	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Outperform ➝ Market Perform
3/7/2025	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Yigal Nochomovitz Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Neutral ➝ Neutral	$28.00 ➝ $19.00	+3.94%
Get the Latest News and Ratings for ARVN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Arvinas and its competitors with MarketBeat's FREE daily newsletter.
2/12/2025	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Bradley Canino Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy ➝ Buy	$63.00 ➝ $51.00	+188.46%
2/7/2025	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Li Watsek Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight
2/3/2025	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Peter Lawson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Overweight ➝ Overweight	$48.00 ➝ $32.00	+81.71%
12/10/2024	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Mukherjee Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$69.00	+175.12%
11/18/2024	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Loganathan Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Overweight	$55.00	+144.66%
3/25/2024	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$65.00	+57.73%
2/22/2024	Leerink Partnrs Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Berens Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform
12/6/2023	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy	$32.00 ➝ $40.00	+38.07%
10/23/2023	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	$70.00 ➝ $55.00	+278.01%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 08:27 PM ET.

ARVN Forecast - Frequently Asked Questions

: According to the research reports of 15 Wall Street equities research analysts, the average twelve-month stock price forecast for Arvinas is $35.50, with a high forecast of $81.00 and a low forecast of $12.00.
: 15 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Arvinas in the last twelve months. There are currently 5 hold ratings and 10 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" ARVN shares.
: According to analysts, Arvinas's stock has a predicted upside of 336.65% based on their 12-month stock forecasts.
: Over the previous 90 days, Arvinas's stock had 3 downgrades by analysts.
: Arvinas has been rated by research analysts at Bank of America, Barclays, BMO Capital Markets, Cantor Fitzgerald, Citigroup, Guggenheim, HC Wainwright, Morgan Stanley, Oppenheimer, Stifel Nicolaus, The Goldman Sachs Group, Wedbush, and Wells Fargo & Company in the past 90 days.
: Analysts like Arvinas less than other "medical" companies. The consensus rating score for Arvinas is 2.67 while the average consensus rating score for "medical" companies is 2.82. Learn more on how ARVN compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top-Rated Stocks

More Ratings Tools

This page (NASDAQ:ARVN) was last updated on 3/25/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Arvinas (ARVN) Stock Forecast & Price Target